tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
PremiumThe FlyPMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
4M ago
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
Premium
Company Announcements
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
4M ago
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
Premium
Ratings
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
4M ago
PMV Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsPMV Pharmaceuticals Reports Q2 2025 Financial Results
7M ago
PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
Premium
The Fly
PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
7M ago
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
Premium
Company Announcements
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
9M ago
PMV Pharmaceuticals Reports Progress in Clinical Trials
PremiumCompany AnnouncementsPMV Pharmaceuticals Reports Progress in Clinical Trials
1y ago
PMV Pharmaceuticals sees cash runway to end of 2026
Premium
The Fly
PMV Pharmaceuticals sees cash runway to end of 2026
1y ago
PMV Pharmaceuticals reports FY24 EPS ($1.14), consensus ($1.02)
Premium
The Fly
PMV Pharmaceuticals reports FY24 EPS ($1.14), consensus ($1.02)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100